Rep. Cuellar, City of Laredo to Announce New CDC Office in Laredo for Zika Virus Detection and Response

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Laredo office will focus on increasing Zika surveillance, prevention and preparation on U.S.-Mexico border from Laredo to Brownsville

 LAREDO, Texas – Congressman Henry Cuellar (D-TX-28) and the City of Laredo Health Department on Tuesday will announce the creation of a new office of the Centers for Disease Control and Prevention (CDC) in Laredo, with three CDC-contracted public health professionals. At the request of Congressman Cuellar, the CDC-contracted health professionals will be stationed in Laredo for one year and will work with health professionals from Laredo to Brownsville to focus on increasing surveillance, prevention, preparation and education to combat the Zika virus. No cases of Zika have been reported in Laredo or Webb County at this time.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

American Cancer Society Updates Prostate Cancer Screening Guideline

The American Cancer Society (ACS) released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease.

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.
- Advertisement -